Capital increase for MyoPowers for an amount of €4,500,000 subscribed mainly by funds generated by Truffle Capital and Novartis Bioventures Limited.
Entering into consortium agreement relating to the “Mivana” project “Innovative medical devices and techniques derived from the textile industry for the creation of a national cardiovascular sector” between Kephalios, Epygon, MDB Texinov and the Institut Français du Textile et de l’Habillement.
Capital increase for Kephalios by contribution of tangible and intangible assets relating to a development and marketing project of a medical device by Mitraflex at Kephalios.
Recent Comments